. . . . . . . . . . . . . . . . "p(HGNC:IL1B) -> tscript(p(HGNC:RELA))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Surprisingly, CSC (1, 2.5, and 5%) treatments did not cause any appreciable increase in NF-kB transactivation at 24 h in A549 cells. In preliminary studies, treatment of rat type II epithelial (L2) cells with CSC (1, 5, and 10%) for 4 h did not increase NF-kB DNA binding as assessed by electrophoretic mobility gel shift assay (data not shown) suggesting that CSC has no effect on NF-kB activation or transactivation in epithelial cells as revealed by various techniques. We also assessed the translocation of the p65 subunit of NF-?B from the cytoplasm to nucleus using the Cellomics Arrayscan technology. Using this technique, we showed increased nuclear p65 in response to IL-1b treatment (Fig. 7B), whereas CSC did not result in translocation of p65 from the cytoplasm to nucleus (data not shown)." . . "Selventa" . . . . "2014-07-03T14:30:28.185+02:00"^^ . . .